Answer
Gaviscon Advance Peppermint is contraindicated in patients with known or suspected hypersensitivity to its active substances or any excipient, including methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216).
Sources for this answer
- Gaviscon Advance - PeppermintReckitt Benckiser Healthcare (UK) Ltd · emc · SmPC §4.3 Contraindications · Version 11Document updated
Sources checked